[1]肖书萍,肖 芳,郑传胜,等.全周期分阶段护理在载药微球治疗肝癌患者中的应用 [J].介入放射学杂志,2020,29(12):1262-1267.
 XIAO Shuping,XIAO Fang,ZHENG Chuansheng,et al.Application of full-cycle phased nursing care in patients with liver cancer receiving drug-loaded microspheres TACE[J].journal interventional radiology,2020,29(12):1262-1267.
点击复制

全周期分阶段护理在载药微球治疗肝癌患者中的应用
()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
29
期数:
2020年12
页码:
1262-1267
栏目:
护理论坛
出版日期:
2020-12-25

文章信息/Info

Title:
Application of full-cycle phased nursing care in patients with liver cancer receiving drug-loaded microspheres TACE
作者:
肖书萍 肖 芳 郑传胜 阚雪峰 饶亚丽 葛 艳 李 玲 陈冬萍
Author(s):
XIAO Shuping XIAO Fang ZHENG Chuansheng KAN Xuefeng RAO Yali GE Yan LI Ling CHEN Dongping.
Department of Radiology, Affiliated Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province 430022, China
关键词:
【关键词】 全周期分阶段护理 载药微球 生命质量满意度
文献标志码:
A
摘要:
【摘要】 目的 探讨以患者护理需求为中心的全周期分阶段护理对进行载药微球(D-TACE)治疗的肝癌患者生命质量、满意度、再入院复查率及脐周腹部脂肪厚度等的影响及应用价值。方法 将入选的90例患者,按随机数字表法分成观察组和对照组各45例。观察组在常规护理与随访的基础上给予全周期分阶段护理,对照组接受介入术后常规护理与随访。分别统计两组手术后、出院后的生命质量、满意度,干预结束时的再入院复查率及干预前、后脐周腹部脂肪厚度指标。结果 ①生命质量:手术后在情感状况维度观察组得分高于对照组(P<0.05),出院后观察组在生理状况、社会/家庭状况、情感状况这3个维度的得分及生命质量总分均高于对照组(P<0.05)。②护理满意度:在手术后和出院后,观察组的满意度均高于对照组(P<0.05)。③再入院复查率:研究结束时,观察组的再入院复查率高于对照组(P<0.05)。④脐周腹部脂肪厚度:观察组干预后脐周腹部脂肪厚度较干预前的减少量明显低于对照组(P<0.05)。结论 D-TACE患者在疾病不同阶段的护理需求是动态变化的,通过前期调研,制订的全周期分阶段护理能针对性改善患者的生命质量,有效提高其满意度、再入院复查率,同时有效维持或减少其身体脂肪流失。护理人员应为其提供个性化的护理服务。

参考文献/References:

[1] 刘 影,张跃伟,郭 志. 微粒TACE治疗肝癌伴富血供门静脉癌栓的初步临床经验[J]. 中华医学杂志, 2014, 94:549-550.
[2] 贺玉晓,石向欣,张韫欢,等. 对比剂肾病的防治进展[J]. 国际泌尿系统杂志, 2019, 39:569-573.
[3] Au TH, Bruckner A, Mohiuddin SM, et al. The prevention of contrast-induced nephropathy[J]. Ann Pharmacother, 2014, 48: 1332-1342.
[4] Kobalava ZD, Villevalde SV, Gaskina AA, et al. Contrast-induced acute kidney injury after primary percutaneous coronary interventions: prevalence,predictive factors,and outcomes[J]. Ter Arkh, 2015, 87: 50-55.
[5] 万崇华,孟 琼,汤学良,等. 癌症患者生命质量测定量表FACT-G中文版评介[J]. 实用肿瘤杂志, 2006, 21:77-80.
[6] 殷 磊. 护理学基础[M]. 北京:人民卫生出版社, 2003:6.
[7] 王会品, 张丽红, 李雷可. 多柔比星载药微球经导管动脉化疗栓塞治疗肝癌临床疗效观察[J]. 中国药师, 2018, 21:654-656.
[8] 张 浩. 肝癌肝动脉栓塞用载药微球的研究现状及进展[J]. 医学临床研究, 2017, 34:341-344.
[9] 王 忠,刘启榆,杨 伟,等. 国产CalliSpheres载药微球DEB-TACE治疗无法手术肝癌的临床价值[J]. 肝脏, 2019, 24:767-770.
[10] 李 红,尹 芳,罗贯虹,等. CalliSpheres载药脂微球联合TACE与传统TACE治疗肝癌疗效对比分析[J]. 胃肠病学和肝病学杂志, 2019, 28:171-174.
[11] 邢冬娟,徐爱民. 微球在肝细胞癌经导管肝动脉化疗栓塞术治疗中的应用及研究进展[J]. 中华肝胆外科杂志, 2011, 17:1023-1026.
[12] Zhang S, Huang C, Li Z, et al. Comparison of pharmacokinetics and drug release in tissues after transarterial chemoembolization with doxorubicin using diverse lipiodol emulsions and Calli-Spheres beads in rabbit livers[J]. Drug Deliv, 2017, 24: 1011-1017.
[13] 曹文婷,胡 琛,李 娟,等. 肝动脉化疗栓塞患者症状及生活质量调查分析[J]. 护理学杂志, 2012, 27:49-51.
[14] 李 晔. 护理干预对介入导管室中肝癌患者治疗效果的影响[J]. 中国临床护理, 2015, 7:109-111.
[15] 徐文茹,徐春兰,杨静姣. 延续性护理模式在肝癌合并糖尿病TACE术后患者的使用效果观察[J]. 实用临床护理学电子杂志, 2019, 4:43- 47.
[16] 朱会利,赵 宁. 强化护理干预对中晚期肝癌患者TACE术后VAS评分及生活质量的影响[J]. 黑龙江医药科学, 2019, 42:215-216.
[17] 张 珊. 集束化护理干预在肝癌病人TACE治疗后护理中的应用[J]. 养生保健指南, 2018, 49:184.
[18] 夏 勇, 沈 锋. 原发性肝癌术后复发的综合防治[J]. 中华肝脏病杂志, 2013, 21:326-328.
[19] 安天志,高 嵩,靳 勇,等. 中国肝细胞癌经动脉化疗栓塞治疗(TACE)临床实践指南[J]. 介入放射学杂志, 2018, 27:1117-1126.
[20] 何志谦. 人类营养学[M]. 北京:人民卫生出版社, 1988:4-8.
[21] Lau WY, Lai ECH. Loco-regional intervention for hepatocellular carcinoma[J]. J Intervent Med, 2019, 2: 43- 46.

相似文献/References:

[1]吴志远,丁晓毅,黄 蔚,等.门脉粒子支架联合载药微球栓塞治疗肝癌7例[J].介入放射学杂志,2017,(02):161.
 WU Zhiyuan,DING Xiaoyi,HUANG Wei,et al.Portal 125I seed stent implantation combined with drug-loaded microsphere embolization for the treatment of HCC: initial results in 7 patients[J].journal interventional radiology,2017,(12):161.
[2]赵 倩,颜志平.载药微球经导管动脉化疗栓塞治疗肝癌研究进展 [J].介入放射学杂志,2017,(11):1052.
 ZHAO Qian,YAN Zhiping.Transarterial chemoembolization with drug- eluting beads for the treatment of hepatocellular carcinoma: recent progress in research[J].journal interventional radiology,2017,(12):1052.
[3]李 鑫,李 臻,李 刚,等.载药微球化疗栓塞治疗下肢梭形细胞肉瘤1例[J].介入放射学杂志,2018,27(02):111.
 LI Xin,LI Zhen,LI Gang,et al.Successful treatment of lower limb spindle cell sarcoma by using chemoembolization with drug- eluting beads: report of one case[J].journal interventional radiology,2018,27(12):111.
[4]于 奇,吴 杰,高 飞,等.载药微球加载贝伐珠单抗治疗难治性实体瘤4例[J].介入放射学杂志,2019,28(01):81.
 YU Qi,WU Jie,GAO Fei,et al.HepaSphere loaded with bevacizumab for the treatment of refractory solid tumors: preliminary results in 4 patients[J].journal interventional radiology,2019,28(12):81.
[5]李亚华,段旭华,韩新巍,等.TACE术中应用三氧化二砷CalliSpheres载药栓塞微球治疗BCLC B期原发性肝癌13例 [J].介入放射学杂志,2019,28(03):232.
 LI Yahua,DUAN Xuhua,HAN Xinwei,et al.TACE by using arsenic trioxide drug- bearing CalliSpheres beads for the treatment of BCLC stage B HCC: preliminary results in 13 patients[J].journal interventional radiology,2019,28(12):232.
[6]翟 越,潘文秋,赵 卫,等.CalliSpheres联合阿帕替尼治疗肝癌的安全性和有效性[J].介入放射学杂志,2020,29(05):462.
 ZHAI Yue,PAN Wenqiu,ZHAO Wei,et al.The safety and effectiveness of CalliSpheres combined with apatinib for the treatment of hepatocellular carcinoma[J].journal interventional radiology,2020,29(12):462.
[7]荆 霞,徐 圣.Callispheres栓塞后综合征的综合护理模式与常规护理模式比较[J].介入放射学杂志,2020,29(07):722.
 JING Xia,XU Sheng..Comprehensive nursing mode versus routine nursing mode for post- embolization syndrome in HCC patients after DEB- TACE: a comparative study[J].journal interventional radiology,2020,29(12):722.
[8]翟越,赵 卫,潘文秋,等.TACE联合载药微球治疗肝癌的研究进展[J].介入放射学杂志,2019,28(12):1211.
 ZHAI Yue,ZHAO Wei,PAN Wenqiu,et al.TACE combined with drug- eluting beads for the treatment of hepatocellular carcinoma: recent progress in research[J].journal interventional radiology,2019,28(12):1211.

备注/Memo

备注/Memo:
(收稿日期:2020-02-18)
(本文编辑:俞瑞纲)
更新日期/Last Update: 2020-12-16